Dr. Gina Ogilvie elected to the Royal Society of Canada for 2024

Dr. Gina Ogilvie, a Professor of UBC’s School of Population and Public Health, has been elected to the Royal Society of Canada (RSC) as part of the RSC College’s 2024 cohort.

Gina Ogilvie is a Tier 1 Canada Research Chair in the Global Control of HPV (human papillomavirus)-Related Disease and Cancer at the University of British Columbia. Her career is dedicated to eliminating cervical cancer in Canada and globally. She is internationally recognized for her research on reduced dosing of the HPV vaccine, improving HPV vaccine uptake, and innovative cervical screening methods, which have transformed health policy globally.

“Throughout my career, I have had the enormous privilege of working with an outstanding team of researchers and clinicians, focused on improving the lives of women and improving women’s health here in Canada and globally,” Dr. Ogilvie said. “I am absolutely delighted that the Royal Society has chosen to recognize the many years work of this team, highlighting how we can work together to eliminate cervical cancer and improve lives worldwide.”

The 2024 cohort includes 104 new Fellows who have been elected by their peers for their outstanding scholarly achievements. They are distinguished individuals from all branches of learning who have made remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life.

The RSC also welcomed 56 new Members to the College. The RSC College is Canada’s first national system of multidisciplinary recognition for the emerging generation of Canadian intellectual leadership.

A total of 15 UBC researchers were announced by the RSC as new Fellows and as new Members of the College of New Scholars, Artists and Scientists. The 2024 Fellows and Members will be welcomed into the RSC in November, at the Celebration of Excellence and Engagement.

Read the full RSC announcement.